Imaging of neck metastases

Chang Gung Medical Journal

Volumn 29, Issue 2, 2006, Pages 119-129

  Ng, Shu Hang ^a   Ko, Sheung Fat ^a   Toh, Cheng Hong ^a   Chen, Yao Liang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cancer staging; CT; Lymph node imaging; Lymph node metastasis; MRI; Nodal morphology; PET; Ultrasound

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ASPIRATION BIOPSY; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DOPPLER FLOWMETRY; FALSE POSITIVE RESULT; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE HYPERPLASIA; LYMPH NODE METASTASIS; MICROMETASTASIS; MORPHOLOGY; NECK DISSECTION; NECK METASTASIS; NECK TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; TREATMENT PLANNING; ULTRASOUND;

HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NECK; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745011189     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Snow GB, Patel P, Leemans CR, Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 1992;249:187-94.
2. Brown AE, Langdon JD. Management of oral cancer. Ann R Coll Surg Engl 1995;77:404-8.
3. Lindberg R. Distribution of cervical LN metastases from SCC of upper respiratory and digestive tracts. Cancer 1972;29:1446-9.
4. Johnson J. A surgeon looks at cervical lymph nodes. Radiology 1990;175:607-10.
5. Vikram B, Strong EW, Shah JP, Spiro R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:730-3.
6. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71:452-6.
7. van den Brekel MWM, Castelijns JA. Radiologic evaluation of neck metastases: the otolaryngologist's perspective. Semin Ultrasound CT MR 1999;20:162-74.
8. Sham JST, Choy D, Wei WI. Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys 1990;19:929-33.
9. Ng SH, Chang JTC, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med 2004;31:1073-80.
10. van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, Meyer CJ, Snow GB. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379-84.
11. Imhof H, Czerny C, Dirisamer A. Head and neck imaging with MDCT. Eur J Radiol 2003;45:23-31.
12. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998;207:123-30.
13. Steinkamp HJ, Maurer J, Heim T, Knobber D, Felix R. Magnetic resonance tomography and computerized tomography in tumor staging of mouth and oropharyngeal cancer. HNO 1993;41:519-25.
14. Glazer H, Niemyer JH, Blafer DM. Neck neoplasms: MRI imaging part I: initial evaluation. Radiology 1986;160:343-8.
15. Wang HM, Ng SH, Wang CH, Liaw CC, Tsai MH, Lai GM. Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent. Cancer 1996;78:1972-9.
16. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 1996;23:717-35.
17. Hao SP, Ng SH. The value of magnetic resonance imaging vs clinical palpation in evaluating cervical metastasis from head and neck cancer. Otolaryngol Head Neck Surg 2000;123:324-7.
18. Som PM, Brandwei M. Lymph nodes. In: Som PM, Curtin HD, eds. Head and Neck Imaging. Vol. 2. 4th ed, St. Louis, MO: Mosby, 2003:1865-934.
19. Baatenburg de Jong RJ, Rongen RJ, De Jong PC, Lameris JS, Knegt P. Screening for lymph nodes in the neck with ultrasound. Clin Otolaryngol Allied Sci 1988;13:5-9.
20. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high resolution US. Radiology 1992;183:215-20.
21. Vassallo P, Edel G, Roos N, Naguib A, Peters PE. In-vitro high-resolution ultrasonography of benign and malignant lymph nodes: a sonographic-pathologic correlation. Invest Radiol 1993;28:698-705.
22. Marchal G, Oyen R, Verschakelen J, Gelin J, Baert AL, Stessens RC. Sonographic appearance of normal lymph nodes. J Ultrasound Med 1985;4:417-9.
23. Ying M, Ahuja A. Sonography of neck lymph nodes. Part I. Normal lymph nodes. Clin Radiol 2003;58:351-8.
24. Ahuja A, Ying M. Sonography of neck lymph nodes. Part II. Abnormal lymph nodes. Clin Radiol 2003;58:359-66.
25. Griffith JF, Chan AC, Ahuja AT, Leung SF, Chow LT, Chung SC, Metreweli C. Neck ultrasound in staging squamous oesophageal carcinoma: a high yield technique. Clin Radiol 2000;55:696-701.
26. van den Brekel MWM, Castelijns JA, Stel HC, Luth WJ, Walk, van der Waal I, Snow GB. Occult metastatic neck disease: detection with ultrasound and ultrasound-guided fine needle aspiration cytology. Radiology 1991;180:457-61.
27. Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics 2003;23:315-40.
28. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-8.
29. Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, Hanafee WN, Maddahi J, Chaiken L, Bailet J. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993;186:27-35.
30. Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, Juillard G, Maddahi J, Phelps ME. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-58.
31. Braams JW, Pruim J, Freling NJ, Nikkels PG, Roodenburg JL, Boering G, Vaalburg W, Vermey A. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG PET and MRI. J Nucl Med 1995;36:211-6.
32. Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau RJ, Herz M, Avril N, Ziegler S, Kruschke C, Arnold W, Schwaiger M. Comparison of fluorine-18- fluorodeoxyglucose PET, MRI, and endoscopy for staging head and neck squamous cell carcinomas. J Nucl Med 1995;36:1747-57.
33. McGuirt WF, Williams DW 3rd, Keyes JW Jr, Greven KM, Watson NE Jr, Geisinger KR, Cappellari JO. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995;105:373-5.
34. Benchaou M, Lehmann W, Slosman DO, Becker M, Lemoine R, Rufenacht D, Donath A. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 1996;116:332-5.
35. Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, Baddeley H, Tierney P, Maisey M. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 1997;22:209-14.
36. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-60.
37. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999;125:1322-8.
38. Nowak B, Di Martino E, Janicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Bull U. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared with CT/MRI. Nuklearmedizin 1999;38:312-8.
39. Stokkel MP, ten Broek FW, Hordijk GJ, Koole R, van Rijk PP. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg 2000;231:229-34.
40. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 2000;28:319-24.
41. Hannah A, Scott AM, Tochon-Danguy H. Evaluation of 18F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002;2:208-17.
42. Hlawitschka M, Neise E, Bredow J, Beuthien-Baumann B, Haroske G, Eckelt U, Franke WG. FDG PET in the pretherapeutic evaluation of primary squamous cell carcinoma of the oral cavity and the involvement of cervical lymph nodes. Mol Imaging Biol 2002;4:91-8.
43. Ng SH, Yen TC, Liao CT, Chang TC, Chan SC, Ko SF, Wang HM, Wong HF. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005;46:1136-43.
44. Ng SH, Chang TC, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 2004;45:1669-76.
45. Ruers TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, Corstens FH, Oyen WJ. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002;20:388-95.
46. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305-32.
47. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, Nuyts JL, Maes FP, Bogaert JG. FDG PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25:1495-501.
48. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.
49. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-7.
50. Kapoor V, Fukui MB, McCook BM. Role of 18F FDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. Am J Roentgenol 2005;184:579-87.
51. Zanation AM, Sutton DK, Couch ME, Weissler MC, Shockley WW, Shores CG. Use, accuracy, and implications for patient management of [18F]-2- fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors. Laryngoscope 2005;115:1186-90.
52. Schwartz DL, Ford EC, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellen B, Mattes D, Kinahan P, Meyer J, Phillips M, Leblanc M, Krohn K, Eary J, Laramore GE. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation. Head Neck 2005;27:478-87.
53. Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-35.
54. Fischbein NJ, Noworolski SM, Henry RG, Kaplan MJ, Dillon WP, Nelson SJ. Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. Am J Neuroradiol 2003;24:301-11.
55. Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, Shigeno K, Hayashi K, Takahashi H, Takashi Nakamura T. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging iIN patients with head and neck cancer. Am J Neuroradiol 2003;24:1627-34.
56. Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion-weighted echoplanar MR imaging. Radiology 2001;220:621-30.
57. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003;228:777-88.
58. Anzai Y, Blackwell KE, Hirschowitz SL, Rogers JW, Sato Y, Yuh WT, Runge VM, Morris MR, McLachlan SJ, Lufkin RB. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994;192:709-15.
59. Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Am J Roentgenol 1999;172:1347-51.
60. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-9.
61. Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd, JH, Reznek RH. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005;23:2813-21.